386915008: Interferon alfa-2b (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b
\Substance categorized by disposition\Immunomodulator\Mediator of immune response and inflammation (substance)\Mediator of immune response\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b
\Substance categorized by disposition\Immunomodulator\Immune enhancement agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Glycoprotein\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Glycoprotein\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b

\Biological substance (substance)\Protein and/or protein derivative\Protein\Glycoprotein\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b
\Biological substance (substance)\Immunologic substance (substance)\Mediator of immune response and inflammation (substance)\Mediator of immune response\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b
\Biological substance (substance)\Polypeptide\Protein\Glycoprotein\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3005892013 Interferon alfa-2b en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3482325017 Interferon alfa-2b (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3216451000005119 interferon alpha-2b da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Interferon alfa-2b	Is a	Immunologic substance (substance)	false	Inferred relationship	Some
Interferon alfa-2b	Is a	Allergen class	false	Inferred relationship	Some
Interferon alfa-2b	Is a	Drug allergen	false	Inferred relationship	Some
Interferon alfa-2b	Is a	Immunomodulator	false	Inferred relationship	Some
Interferon alfa-2b	Is a	Interferon	false	Inferred relationship	Some
Interferon alfa-2b	Is a	interferon alfa	false	Inferred relationship	Some
Interferon alfa-2b	Is a	Interferon alfa (substance)	true	Inferred relationship	Some
Interferon alfa-2b	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some
Interferon alfa-2b	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antiviral (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing interferon alfa-2b (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Some	1
Interferon-A-2b adverse reaction	Causative agent	True	Interferon alfa-2b	Inferred relationship	Some	1
Allergy to interferon alfa-2b (finding)	Causative agent	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 10 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 5 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 3 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 1 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 6 MIE/ml injektionsvæske, opløsning, hætteglas a 3 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 15 MIE/1 ml fyldt pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 25 MIE/1 ml fyldt pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 50 MIE/1 ml fyldt pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 10 MIE/ml injektionsvæske, opløsning, hætteglas a 2,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
Peginterferon alfa-2b (substance)	Is a	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 5 MIE/pulver, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 25 MIE/pulver, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 50 MIE/pulver, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 10 MIE/hætteglas pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 3 MIE/pulver, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 18 MIE/pulver, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 25 MIE/opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 18 MIE/opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
Interferon alfa-2b 10 million iu/vial solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 3 MIE/opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 5 MIE/opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 30 MIE opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 60 MIE/IE opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 150 µg pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 300 µg pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 120 µg pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 600 µg pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 100000 µg pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 50 µg pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
interferon alfa-2b 10 MIE/2 ml injektionsvæske, opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
ribavirin + interferon alfa-2b	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
Allergy to interferon alfa-2b (finding)	Causative agent	True	Interferon alfa-2b	Inferred relationship	Some	1
Product containing interferon alfa-2b in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Some	1
Interferon alfa-2b 10million iu powder for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
Interferon alfa-2b 3million iu powder for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
Interferon alfa-2b 5million iu powder for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Some
Interferon alfa-2b 1 million unit powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Interferon alfa-2b	Inferred relationship	Some	1
Interferon alfa-2b 1 million unit powder for solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1
Interferon alfa-2b-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Some	1
Interferon alfa-2b only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Some	1
Product containing only interferon alfa-2b in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Some	1
Interferon alfa-2b only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Interferon alfa-2b	Inferred relationship	Some	1
Peginterferon alfa-2b (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Interferon alfa-2b	Inferred relationship	Some
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1
Ropeginterferon alfa-2b	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Interferon alfa-2b	Inferred relationship	Some
Product containing precisely interferon alfa-2b (as ropeginterferon alfa-2b) 500 microgram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Interferon alfa-2b	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3005892013	Interferon alfa-2b	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3482325017	Interferon alfa-2b (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3216451000005119	interferon alpha-2b	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)